A prevalent bacterium, frequently implicated in respiratory ailments such as pneumonia and sinus infections, has been identified as a potential contributor to the progression of Alzheimer’s disease. Researchers at Cedars-Sinai have presented compelling evidence suggesting that Chlamydia pneumoniae can establish a persistent presence within both ocular and cerebral tissues, potentially exacerbating the neurodegenerative damage characteristic of Alzheimer’s. The groundbreaking findings, detailed in the scientific journal Nature Communications, illuminate the critical role of chronic infection and inflammation, thereby opening avenues for innovative therapeutic strategies. These may encompass the judicious application of antibiotics in early stages and the development of targeted anti-inflammatory interventions.
For the first time, scientific investigation has definitively demonstrated the ability of Chlamydia pneumoniae to migrate to the retina, the light-sensitive membrane lining the back of the eye. Upon its arrival in the retinal tissue, the bacterium triggers immune responses that are intrinsically linked to inflammation, the progressive loss of neuronal cells, and a subsequent decline in cognitive faculties. This revelation underscores the intricate interplay between microbial invasion and the delicate neurological environment.
"The consistent observation of Chlamydia pneumoniae across diverse human tissues, in controlled laboratory cell cultures, and within experimental animal models has enabled us to delineate a hitherto unrecognized correlation between bacterial infection, the resultant inflammatory cascade, and the process of neurodegeneration," stated Maya Koronyo-Hamaoui, PhD, a distinguished professor holding joint appointments in Neurosurgery, Neurology, and Biomedical Sciences at Cedars-Sinai Health Sciences University, and the principal senior author of this seminal study. She elaborated on the significance of the eye as a proxy for the brain: "The eye serves as a remarkably accurate surrogate for the brain. This research unequivocally demonstrates that persistent bacterial infection within the retina and the ensuing chronic inflammation can serve as a faithful reflection of underlying brain pathology and act as a predictor of disease status. Consequently, retinal imaging emerges as a highly promising non-invasive modality for identifying individuals at elevated risk for developing Alzheimer’s disease."
Analysis of retinal tissue samples from a cohort of 104 individuals, encompassing those with normal cognitive function, mild cognitive impairment, and confirmed Alzheimer’s disease, was conducted using sophisticated imaging techniques, advanced genetic analysis, and comprehensive protein studies. This meticulous examination revealed a pronounced correlation: individuals diagnosed with Alzheimer’s disease exhibited significantly higher concentrations of Chlamydia pneumoniae in both their retinal and brain tissues when juxtaposed with participants exhibiting unimpaired cognitive abilities. Furthermore, the research team observed a direct relationship between the quantity of the bacterium present and the severity of brain damage, as well as the degree of cognitive decline experienced by the patients.
This elevated presence of bacterial loads was particularly pronounced among individuals who carry the APOE4 gene variant, a well-established genetic marker known to substantially increase an individual’s susceptibility to developing Alzheimer’s disease. This observation further solidifies the link between genetic predisposition and the potential influence of infectious agents in disease pathogenesis.
To rigorously validate the hypothesized connection, the research team embarked on further experimental investigations, employing both human neuronal cell cultures in a laboratory setting and a murine model engineered to exhibit characteristics of Alzheimer’s disease. In both experimental paradigms, the introduction of Chlamydia pneumoniae infection consistently resulted in heightened inflammatory responses, an accelerated rate of neuronal cell death, and a marked exacerbation of cognitive deficits. Crucially, the bacterial infection was also found to stimulate the production of amyloid-beta, the misfolded protein that characteristically aggregates to form plaques in the brains of individuals afflicted with Alzheimer’s disease.
The comprehensive study was co-led by Bhakta Gaire, PhD, and Yosef Koronyo, MSc, who served as co-first authors. Their collaborative efforts were instrumental in advancing the research to its significant conclusions.
"This pivotal discovery fundamentally alters our perspective on Alzheimer’s treatment, presenting the compelling possibility of targeting the intricate axis of infection and inflammation as a novel therapeutic strategy," remarked Timothy Crother, PhD, a co-corresponding author of the study and a research professor at Cedars-Sinai Guerin Children’s and the Department of Biomedical Sciences at Cedars-Sinai. His statement highlights the paradigm shift this research could usher in for therapeutic development.
Collectively, the findings strongly suggest that addressing and effectively treating chronic bacterial infections, along with the persistent inflammation they instigate, could represent a groundbreaking new frontier in the management and potential prevention of Alzheimer’s disease. These results also lend substantial credence to the utility of the retina as a non-invasive diagnostic tool, capable of facilitating the early detection and ongoing monitoring of Alzheimer’s disease progression. The implications for public health and patient care are profound, offering hope for earlier interventions and more personalized treatment approaches.
The extensive list of contributing authors from Cedars-Sinai includes Bhakta Gaire, Yosef Koronyo, Jean-Philippe Vit, Alexandre Hutton, Lalita Subedi, Dieu-Trang Fuchs, Natalie Swerdlow, Altan Rentsendorj, Saba Shahin, Daisy Martinon, Edward Robinson, Alexander V. Ljubimov, Keith L. Black, Jesse Meyer, and Moshe Arditi. Additional contributions were made by Julie A. Schneider, Lon S. Schneider, Debra Hawes, Stuart L. Graham, Vivek K. Gupta, and Mehdi Mirzaei from other institutions.
This significant body of research was made possible through the generous support of several esteemed funding bodies. Grants from the National Institutes of Health (NIH) and the National Institute on Aging (NIA), specifically R01AG056478, R01AG055865, and AG056478-04S1, provided crucial financial backing for M.K.H. Further support was garnered from NIH/NIA grants R01AG075998, awarded to M.K.H. and T.R.C., and an Alzheimer’s Association grant, AARG-NTF-21-846586, to T.R.C. M.K.H. also received support from The Goldrich and Snyder Foundations, while E.R. was supported by The Ray Charles Foundation. The collaborative and well-funded nature of this research underscores its importance and the dedication of the scientific community to unraveling the complexities of Alzheimer’s disease.
About the Author
